- Subscribe to JETLaw
- Volume 15
- Volume 14
- Volume 13
- Volume 12
- Volume 11
- Volume 10
- Volume 9
- Volume 8
- Volume 7
- Volume 6
- Volume 5
- Volume 4
- Volume 3
- Volume 2
- Publish With JETLAW
Currently viewing the tag: "Pfizer"
Scientists use brain scans to determine what makes long-term marriages last.
David Carradine’s widow files wrongful death suit against French production company.
MPAA considers whether to turn its litigious attentions to Ashton Kutcher for pirating a portion of his upcoming movie.
[...]Continue Reading →
I respect the time, effort, and money that pharmaceutical companies devote to drug research and development, and advertising the drugs that are ultimately developed is an inevitable part of the research and [...]Continue Reading →
In the news . . .
Wired writer tries to find out if it’s possible to disappear in the digital world.
England’s proposed new copyright laws are extremely controversial.
Insurance company takes away Canadian woman’s long-term sick leave benefit after Facebook photos indicate she wasn’t suffering [...]Continue Reading →
Pfizer offered a major “mea culpa” last week when it agreed to pay $2.3 billion in fines for the “largest combined federal and state health care fraud settlement in the history of the Department of Justice.” The pharmaceutical company has ended up in this less than esteemed position as a result of [...]Continue Reading →
On October 7, 2008 By JETLaw
Pfizer, Inc., the world’s largest research-based pharmaceutical company, announced on October 1 that it plans to discontinue research and development in the areas of heart disease, cholesterol, obesity and bone health. The company predicated its decision on the scheduled 2011 expiration of the company’s patent for its bestselling, cholesterol-reducing drug, Lipitor. Research [...]Continue Reading →